The BBRY Café. [Formerly: I support BBRY and I buy shares!]
View Poll Results: Did you buy shares ?
- Voters
- 1129. You may not vote on this poll
-
-
Then I searched BlackBerry for latest news and kind of felt that it was good time to cross 4K shares mark so I bought myself a few more.04-08-14 11:04 AMLike 3 - Superfly_FRRetired ModeratorCombo for you :
http://forums.crackberry.com/news-ru...uction-922112/
http://forums.crackberry.com/news-ru...evices-922069/
http://forums.crackberry.com/news-ru...y-name-922067/
Forum is sick, have to go ... big Football match tonight for me Parisian !!!
Allez Paris !04-08-14 12:35 PMLike 14 - Not sure we really bother with what those clever analysts think but since it's a slow news day... a bit of a bone to chew on!
BlackBerry (TSE: BB) received a number of ratings updates from brokerages and research firms in the last week:
BlackBerry had its price target raised by analysts at UBS AG from C$8.00 to C$8.50. They now have a “neutral” rating on the stock.
BlackBerry had its price target lowered by analysts at Goldman Sachs from C$9.50 to C$8.80. They now have a “neutral” rating on the stock.
BlackBerry had its price target raised by analysts at Canaccord Genuity from C$6.00 to C$8.00. They now have a “hold” rating on the stock.
BlackBerry had its price target raised by analysts at Nomura from C$7.00 to C$9.00. They now have a “neutral” rating on the stock.
BlackBerry was downgraded by analysts at Credit Suisse to an “underperform” rating.
BlackBerry had its price target raised by analysts at Robert W. Baird from C$7.00 to C$8.00. They now have a “neutral” rating on the stock.
BlackBerry was downgraded by analysts at Evercore Partners from an “equal weight” rating to an “underweight” rating. They now have a C$6.00 price target on the stock, down previously from C$7.00.
BlackBerry had its “sector perform” rating reaffirmed by analysts at Scotiabank. They now have a C$9.15 price target on the stock, up previously from C$8.40.
BlackBerry was downgraded by analysts at CSFB from a “neutral” rating to an “underperform” rating. They now have a C$6.00 price target on the stock, down previously from C$7.00.
BlackBerry was upgraded by analysts at Needham & Company LLC from an “underperform” rating to a “hold” rating.
BlackBerry Ltd (TSE:BB) traded up 1.16% during mid-day trading on Tuesday, hitting $8.72. 1,842,269 shares of the company’s stock traded hands. BlackBerry Ltd has a 52-week low of $5.79 and a 52-week high of $12.59. The stock’s 50-day moving average is $10.31 and its 200-day moving average is $8.83. The company’s market cap is $4.525 billion.04-08-14 03:54 PMLike 6 - Well if we had the "brilliance" in marketing and spin of the "other" fruit company we could call it the Z3S! ROFL!04-08-14 04:00 PMLike 5
- Ain't that the truth. I have been avoiding my favorite thread because of this ongoing behavior!
Posted with my gorgeous Z3004-08-14 05:56 PMLike 3 -
Here's the deal. While things are mainly good here on the busiest and best BlackBerry forum on the net, a lot of members, including myself, are starting to get really annoyed with some of the posts being made by a small minority of individuals. These are the members who consistently have nothing but bad things to say. They don't necessarily "break the forum rules", but they know them well and play them like a fiddle so they can persist in the forums. These people bring it down for everybody else.
However, if a single member is going to bring this community down by their consistent negative contributions and never add anything of merit or substance to the forums, I'd rather them not be a member at all (even if they didn't "break" the rules). I'd rather have a smaller forum community vs. a bigger community that is infested with trolls.
04-08-14 06:05 PMLike 2 - No longer.
Another Mod missed it on the first strafing run, but it's all gone now.
And you can thank Mr. Bla1ze for sending one more troll back to his bridge in parts unknown.04-08-14 06:40 PMLike 19 -
-
-
- OT: OK damn, mods deleted my post... For obvious reasons ha! Sorry Morgan, you would have really enjoyed it.
Anywhoo, hopefully this one comes clean!
There is still tons of optimism on BB it seems, I personally haven't kept up to date with the company, but they are still around (I thought they should have gone bankrupt like analysts were sayin... Ha!). The one thing I do like is the new CEO, he is a great fit and has the poise to lead this company.
Couple more things... I started a new job, so I finally got things going back up again... This means no more vacations to J land until next year... A few of you previously asked about SFX Entertainment a while ago and their IPO. I stated that i would be hesitant in investing in such a company (more so because I morally am against what they are doing). Their stock has fallen greatly and their CEO makes Heins look like a genious...
SFX CEO Robert Sillerman Flips Bird, Grabs Crotch While Exiting Private Jet - Business Insider
And finally, thanks Corbu for the PM on Frankie Knuckles... A sad week indeed for us DJ's and House music lovers... He was our hero and inspiration.
Good luck everyone!04-08-14 09:13 PMLike 9 -
Hi Slipstream89!!
I see the last time I created a chart for BBRY, we were forming our first uptrend line. Since then, it has broken down in every way possible for the short-term. That was a month ago, we not only showed some signs of life, we had a Golden Cross to go with it but the Q4 report wasn't strong enough on Revenues to provide "news" related support. So where are we now?
Attachment 261725
In my opinion, we are back down to support with the Bollinger Bands telling us that there is limited downside followed by the RSI=30 with a double bounce off that level. I see the stock falling back along a downward channel back to the bottom of a series of support/resistance levels. We can move sideways here with a range of $ 8.00 to $ $ 10.80/shr now which is your $ 12.00/shr/CDN exit point. We have a minor resistance point at $ 8.50/shr/US, of course there are those averages, the 50-dma and the 200-dma which, crazy as it may, are still bullish short-term. When we close above those levels we are more than likely to make a run for the top of the channel in the next couple of months which is hard resistance at $ 10.80/shr..
Not a fire-storm of strength here, more of a chart pattern that buys us time for BB to launch new products and get promises to market. If they could have delivered decent revenues, we wouldn't have had to sit this rally out. The same can be said for AAPL and others within the tech sector, many are moving sideways or breaking down here. I'm a buyer at $ 8.00/shr (have been for a week now) using Puts now to acquire the stock at $ 7.50/shr. It's boring for a couple of months but during that time we'll challenge those averages again soon. Best of luck.04-09-14 07:00 AMLike 12 - OT: Things just keep getting worse for $halo..
FDA halts PEGPH20 trial: The FDA places Halozyme's (HALO) pancreatic cancer Phase 2 trial on clinical hold. The agency takes action on the basis of the company's recent decision to stop the trial while it investigates possible differences in thromboembolic events between the PEGPH20 and non-PEGPH20 groups.
Morgan, what are you thoughts on this whole fiasco? I am in deep and feel like I am living the same nightmare as BBRY when it went from $18 to single digits (same pattern as $halo)04-09-14 07:45 AMLike 0 - OT: Things just keep getting worse for $halo..
FDA halts PEGPH20 trial: The FDA places Halozyme's (HALO) pancreatic cancer Phase 2 trial on clinical hold. The agency takes action on the basis of the company's recent decision to stop the trial while it investigates possible differences in thromboembolic events between the PEGPH20 and non-PEGPH20 groups.
Morgan, what are you thoughts on this whole fiasco? I am in deep and feel like I am living the same nightmare as BBRY when it went from $18 to single digits (same pattern as $halo)
I have a small fortune in HALO too, this news today is the result of HALO pausing their Phase II study and is a normal reaction to that effort. The price of the stock has discounted the study all together, actually, it has discounted the stopping of the study and all other studies related to the PEGPH20 drug program. The Biotech sector is under water in every case, there isn't a stock that is holding up under the selling pressure right now. This is because so many hold large profits in this sector and they are rotating out of the sector for now. Management at HALO can't do much more than provide all of their clinical data to date and have the independent study group review their data to see if PEGPH20 has anything to do with the uptake in blood clotting in old patients with Pancreatic Cancer. It is normal for patients to develop platelets under late stage P/C, a treatment for these patients needs to be included in the Phase II study whether it relates to HALO or not. PEGPH20 is part of a two stage study here with two other drugs that have their own properties. The problem of platelet growth has never been related to PEG before this point, but it needs to be cleared up so that the study as a whole, can proceed. I know, it is difficult to believe that HALO and BBRY are trading at the same price but its a fact and one we'll need to accept for a few weeks time until they clear up next steps. If the sector were strong, no one would care that the FDA did the official halt because it was expected from the time the Independent Group suggests the company pause to review its clinical data. The company is so much more than this one PHII trial, it has a novel drug delivery program that all of the big Pharmas are adopting. As BMO said, this Phase II study represents only $ 1.00/shr to HALO in stock value. That's about all I can say right now, the PEG drug itself is saving lives, or at least, it is prolonging death and that is going to be considered when judging any data on platelet growth in 30% of patients. Most patients will demand the drug and take a blood thinner and move on if they can increase their life expectancy by a large percentage. Hope this helps.
PS. One more thing to consider, the expectancy of platelets in this study is likely set at 30%, they are enrolling patients into the study, many of whom will develop platelets regardless of the drugs used as this is part of the breaking down of the defensive process of late stage P/C. So if only 30 people have enrolled in the study and taken the drug cocktail for 28 days, the data can easily be miss-leading with such a small sample. If you are expecting 9 patients to develop platelets or clotting and you get 11, what do you do? You have another look at the data that is ongoing and new versus the 28 day/ 30 patient list.04-09-14 08:06 AMLike 10 - Thank you Morgan! As always, appreciate your thoughts, your knowledge, and positivity about $halos future. Thanks for sharing04-09-14 08:18 AMLike 3
- I guess reputation is everything?
Samsung sues South Korean newspaper for writing a negative story - The Times of India http://timesofindia.indiatimes.com/t...w/33502648.cms04-09-14 08:37 AMLike 5 - Good Move,
However BES is not effected.
Canada Revenue Agency shuts online service to guard against Heartbleed bug - The Globe and Mail http://www.theglobeandmail.com/techn...Business+News)04-09-14 08:41 AMLike 2 - Unipresalud upgrades to BlackBerry Enterprise Service 10
Wednesday 9 April 2014 | 15:23 CET | News
BlackBerry announced that Unipresalud, a Spain-based consultancy specialised in risk prevention and in the improvement of workplace health and safety, upgraded to BlackBerry’s Enterprise Mobility Management (EMM) platform, BlackBerry Enterprise Service 10 (BES 10), to meet its stringent data protection needs for mobile communications.
Unipresalud, which has accreditation by Spain’s National Labor Authority (Direccion General de Trabajo) to provide external occupational risk prevention services, has an 850-strong team of professional staff, and more than 120 service centres and 22 mobile units.
To support a highly mobile workforce, Unipresalud needed a platform that could meet its primary goal, namely providing best in class security management for the storage and exchange of corporate information. Unipresalud deployed BES 10 to meet this mobility requirement and is one of the first major companies in Spain to adopt Blackberry’s new EMM platform.
As its main activity relates to occupational health, Unipresalud regularly manages sensitive data protected by Spain’s stringent Organic Law on Data Protection (LOPD). The service guarantee offered by the company requires a robust mobility strategy to ensure the secure and confidential handling of medical information of corporate client employees, as well as the reliable management of its business processes. Unipresalud has deployed BlackBerry 10 smartphones to regional managers, making it easier for them to communicate with each other through a mobile platform.
Unipresalud is evaluating the usage and roll-out of BES 10’s Secure Work Space in its Android devices. Secure Work Space supports both personal and work use by creating a separate, secure and clearly differentiated work environment on the smartphone. It leverages the same trusted behind-the-firewall connection available for BlackBerry smartphones and extends BlackBerry security capabilities for data-at-rest and data-in-transit to Android and iOS devices.04-09-14 08:59 AMLike 12 - It's getting brutal out there.
Samsung drops price 10% on latest flagship phone just days before worldwide launch:
In smartphone mass-market, Samsung, Apple have margins on their minds
SEOUL (Reuters) - As the smartphone action shifts to the mass market, leaders Samsung Electronics Co Ltd and Apple Inc are under pressure to make their high-end phones more affordable to revive sales. And that may spell trouble for already-softening margins.
Samsung, which said on Tuesday it would likely post a second straight quarterly profit decline, has knocked around a tenth off the price of its Galaxy S5 in South Korea, in the first such move for a marquee smartphone launch - the S5 rolls out globally on Friday. And it's throwing in a free gift pack of media subscriptions and web apps worth 600,000 won ($570).
The mass market - where a smartphone can be had for as little as $25 - is the new mobile device battleground, as high-end growth eases off with sales slowing in mature markets.04-09-14 09:43 AMLike 5
- Forum
- Popular at CrackBerry
- General BlackBerry News, Discussion & Rumors
- BBRY
The BBRY Café. [Formerly: I support BBRY and I buy shares!]
Similar Threads
-
The importance of a removable battery.
By krzyabn in forum BlackBerry KEY2Replies: 45Last Post: 04-15-19, 10:12 PM -
Motion support - Vibration no longer working and I need advice!
By bunnyraider in forum BlackBerry MotionReplies: 1Last Post: 04-12-19, 09:42 PM -
Will BlackBerry Launcher ever give us the option to swipe up?
By ikeike859 in forum BlackBerry Android OSReplies: 8Last Post: 04-12-19, 06:27 PM -
In MIXplorer, what is the "archive?"
By RLeeSimon in forum Android AppsReplies: 3Last Post: 04-12-19, 05:00 PM -
Skype Preview brings screen sharing to Android and iOS
By CrackBerry News in forum CrackBerry.com News Discussion & ContestsReplies: 0Last Post: 04-12-19, 01:51 PM
Tags for this Thread
LINK TO POST COPIED TO CLIPBOARD